These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9829757)

  • 1. Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate.
    Berg SL; Murry DJ; McCully CL; Godwin K; Balis FM
    Clin Cancer Res; 1998 Nov; 4(11):2891-4. PubMed ID: 9829757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and time course of peripheral blood mononuclear cell O6-methylguanine-DNA methyltransferase inhibition in the nonhuman primate.
    Berg SL; Gerson SL; Godwin K; Cole DE; Liu L; Balis FM
    Cancer Res; 1995 Oct; 55(20):4606-10. PubMed ID: 7553637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
    Long L; Berg SL; Roy SK; McCully CL; Song-Yoo HW; Moschel RC; Balis FM; Dolan ME
    Clin Cancer Res; 2000 Sep; 6(9):3662-9. PubMed ID: 10999759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.
    Stefan TL; Ingalls ST; Minkler PE; Willson JK; Gerson SL; Spiro TP; Hoppel CL
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):289-98. PubMed ID: 9518162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of O6-benzylguanine in rats and its metabolism by rat liver microsomes.
    Roy SK; Gupta E; Dolan ME
    Drug Metab Dispos; 1995 Dec; 23(12):1394-9. PubMed ID: 8689950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanine.
    Tserng KY; Ingalls ST; Boczko EM; Spiro TP; Li X; Majka S; Gerson SL; Willson JK; Hoppel CL
    J Clin Pharmacol; 2003 Aug; 43(8):881-93. PubMed ID: 12953345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study.
    Neville K; Blaney S; Bernstein M; Thompson P; Adams D; Aleksic A; Berg S
    Clin Cancer Res; 2004 Aug; 10(15):5072-5. PubMed ID: 15297409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
    Schilsky RL; Dolan ME; Bertucci D; Ewesuedo RB; Vogelzang NJ; Mani S; Wilson LR; Ratain MJ
    Clin Cancer Res; 2000 Aug; 6(8):3025-31. PubMed ID: 10955780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings.
    Dolan ME; Roy SK; Fasanmade AA; Paras PR; Schilsky RL; Ratain MJ
    J Clin Oncol; 1998 May; 16(5):1803-10. PubMed ID: 9586894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
    Dolan ME; Chae MY; Pegg AE; Mullen JH; Friedman HS; Moschel RC
    Cancer Res; 1994 Oct; 54(19):5123-30. PubMed ID: 7923129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal administration of topotecan in nonhuman primates.
    Blaney SM; Cole DE; Godwin K; Sung C; Poplack DG; Balis FM
    Cancer Chemother Pharmacol; 1995; 36(2):121-4. PubMed ID: 7767947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral O6-benzylguanine and evidence of interaction with oral ketoconazole in the rat.
    Ewesuedo RB; Dolan ME
    Cancer Chemother Pharmacol; 2000; 46(2):150-5. PubMed ID: 10972485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
    Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
    Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate.
    Heideman RL; McCully C; Balis FM; Poplack DG
    Invest New Drugs; 1993; 11(2-3):135-40. PubMed ID: 7505267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
    Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
    Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
    Mitchell RB; Moschel RC; Dolan ME
    Cancer Res; 1992 Mar; 52(5):1171-5. PubMed ID: 1737376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
    Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of intracranial and intraperitoneal O6-benzyl guanine in combination with BCNU delivered locally in a mouse model.
    Guarnieri M; Biser-Rohrbaugh A; Tyler BM; Gabikian P; Bunton TE; Wu QZ; Weingart J; Carson BS
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):392-6. PubMed ID: 12439597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
    Wedge SR; Porteous JK; Newlands ES
    Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.